Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 396
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06090630 | MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer | ||
| NCT00278187 | Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | ||
| NCT04457232 | Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation | ||
| NCT05160597 | Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy | ||
| NCT04069923 | OsteoCrete in Filling Bone Voids in Participants With Bone Voids or Defects | ||
| NCT01051037 | Stereotactic Body Radiotherapy and Radiofrequency Ablation for Lung Tumors Near Central Airways | ||
| NCT01591577 | Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme | ||
| NCT00004878 | Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia | ||
| NCT00047255 | Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer | ||
| NCT00444223 | Fluorine F 18 FEQA in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer and in Healthy Participants | ||
| NCT03515577 | Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery | ||
| NCT02830165 | Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery | ||
| NCT06047509 | Focal Laser Ablation of Prostate Cancer: A Feasibility Study Using MRI/US Image Fusion for Guidance | ||
| NCT01813877 | Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma | ||
| NCT04553770 | Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer | ||
| NCT00880542 | Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery | ||
| NCT05457959 | Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant | ||
| NCT03148327 | Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy | ||
| NCT01540955 | Cognitive Rehabilitation Group Intervention for Breast Cancer Survivors | ||
| NCT00276614 | Bortezomib in Treating Patients With Metastatic Kidney Cancer | ||
| NCT01351220 | Community Dissemination of an Evidence-based Colorectal Cancer (CRC) Screening Intervention | ||
| NCT00005617 | Vaccine Therapy in Treating Patients With Stage IV or Relapsed Malignant Melanoma | ||
| NCT04299113 | Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent Rhabdomyosarcoma | ||
| NCT03601455 | Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer | ||
| NCT03732950 | Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer | ||
| NCT04290897 | Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors | ||
| NCT07077239 | Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity | ||
| NCT03672773 | Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer | ||
| NCT00005083 | Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors | ||
| NCT00012142 | CCI-779 in Treating Patients With Prostate Cancer | ||
| NCT01574222 | A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung Cancer | ||
| NCT02681601 | Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer | ||
| NCT00100997 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate | ||
| NCT00004880 | Vaccine Therapy in Treating Patients With Advanced Kidney Cancer | ||
| NCT00003320 | Radiation Therapy Following Surgery to Remove Brain Metastases | ||
| NCT01990196 | Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer | ||
| NCT00093769 | Bortezomib and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma | ||
| NCT00612001 | Vaccine Therapy in Treating Patients With Malignant Glioma | ||
| NCT00096239 | CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | ||
| NCT00112775 | BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate | ||
| NCT02176902 | Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer | ||
| NCT02296229 | Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer | ||
| NCT00253617 | Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery | ||
| NCT00005084 | Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma | ||
| NCT01873248 | Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective | ||
| NCT00081068 | Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia | ||
| NCT07323641 | Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer | ||
| NCT04857502 | 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer | ||
| NCT00107185 | Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant Glioma | ||
| NCT00335868 | PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy |
